Guillain-Barré syndrome associated with COVID- 19 vaccination: a case report
Keywords:Guillain-Barre syndrome, COVID-19 vaccine, AIDP, ChAdOx1-n-CoV-19, Covishield
Several reports and studies are being conducted to this day based on the safety profile of COVID-19 vaccines. COVID-19 vaccination inducing GBS is a rare adverse effect and is likely to be causal. Though, there are reports concerning the relation between coronavirus infections and GBS, the pathogenic mechanism and relevant factors behind COVID-19 vaccines inducing GBS are still not being corroborated so far. Guillain-Barre syndrome is the principal cause of acute flaccid paralysis with a prevalence rate of 2 in 100, 000 people per year. We illustrate a 55 years old female patient who presented with acute onset paraesthesia and progressive weakness of bilateral lower limbs and gait imbalance of 5 days duration to the Hospital during the first week of September. Her symptoms occurred within 2 weeks of the first dose of the ChAdOx1-n-CoV-19 (Covishield) vaccine proving a major possibility of vaccine-induced neurological adverse effect as she didn't have any likely significant history of illness or allergies in the past rather than type 2 diabetes mellitus. This report aims to highlight the incidence and to ruminate upon this matter while evaluating any GBS cases in the current eras of the COVID-19 pandemic and vaccination.
Seven cases of neuro disorder among Covishield recipients. Available at: https://www.deccanherald. com/national/kerala-doctors-find-7-cases-of-rare-neuro-disorder-among-covishield-recipients-1001092.html. Assessed on 28 September 2021.
Hasan T. Case of Guillain- Barré syndrome following COVID-19 vaccine. BMJ Case Rep. 2021;14:1-4.
Guillain-Barré Syndrome. Available at: https://rarediseases.org/rare-diseases/guillain-barre-syndrome/. Assessed on 28 September 2021.
Covid vaccine: India drones deliver Covid jabs to remote areas. BBC News. Available at: https://www.bbc.com/news/world-asia-india-56345591. Assessed on 29 September 2021.
Waheed S. Neurological Complications of COVID-19: Guillain- Barre Syndrome Following Pfizer COVID-19 Vaccine. Cureus. 2021;13(2):1-4.
Neurological Disorders – adverse events associated with childhood vaccines. ncbi bookshelf. Available at: https://www.ncbi.nlm.nih.gov/books/NBK236 298/. Assessed on 1 October 2021.
Leonhard SE, Mandarakas MR, Gondim FAA. Diagnosis and management of Guillain- Barré syndrome in ten steps. Nat Rev Neurol. 2019;15:671-83.
Maramattom BV, Krishnan P, Paul R. Guillain- Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine. Ann Neurol. 2021;90:312-4.
Patel SU. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021;14:1-5.
Zito A, Alfonso E, Franciotta D. COVID-19 and Guillain- Barré Syndrome: a case report and review of literature. Front Neurol. 2020;11:1-6.